Bascom Palmer adopts Beyeonics One system for immersive ophthalmic surgery
Products

Bascom Palmer adopts Beyeonics One system for immersive ophthalmic surgery

First digital microscope with augmented reality headset will be integrated into the institute’s educational surgical training program.
Lighthouse Guild selects accessibility innovator as new leader
Business

Lighthouse Guild selects accessibility innovator as new leader

President and CEO of Guiding Eyes for the Blind Thomas Panek will take the helm starting next month.
Phase 4 data presents early patient-reported outcomes of MIEBO
Pipeline

Phase 4 data presents early patient-reported outcomes of MIEBO

Study finds symptom relief achieved as early as 5 to 60 minutes on day 1 of dosing—with significant reduction in overall severity after 14 days.
Iantrek reports favorable 2-year data on uveoscleral outflow technology for glaucoma
Research

Iantrek reports favorable 2-year data on uveoscleral outflow technology for glaucoma

New study details favorable safety profile of the CycloPen System as a bio-interventional platform for OAG patients undergoing combined cataract surgery.
Could GLP-1 receptor agonists reduce AMD risk?
Research

Could GLP-1 receptor agonists reduce AMD risk?

GLP-1 receptor agonists demonstrate a notable effect on the risk of non-exudative AMD.
 Kodiak Sciences concludes enrollment for phase 3 DR on tarcocimab
Pipeline

Kodiak Sciences concludes enrollment for phase 3 DR on tarcocimab

Anti-VEGF tarcocimab tedromer is under clinical investigation as a mainstay IVT monotherapy with twice-yearly dosing for three retinal indications.
FDA approves expanded label of ILUVIEN for chronic posterior uveitis
Products

FDA approves expanded label of ILUVIEN for chronic posterior uveitis

Updated label for sustained-release fluocinolone acetonide intravitreal implant now includes noninfectious uveitis affecting the posterior segment of the eye.
Which is more effective for astigmatism: toric IOLs or FSAK?
Research

Which is more effective for astigmatism: toric IOLs or FSAK?

Despite comparable clinical outcomes, toric IOLs may have better efficacy for moderate and ATR astigmatism.
Harrow launches VEVYE accessibility program for patients
Products

Harrow launches VEVYE accessibility program for patients

VEVYE Access for All initiative eliminates prior authorization submission delays, expedites prescription deliveries, and lowers prescription costs for qualifying patients.
Tenpoint Therapeutics names veteran executive as first CCO
Business

Tenpoint Therapeutics names veteran executive as first CCO

Carol Kearney to lead company’s efforts to launch and expand global availability of BRIMOCHOL PF for presbyopia.
Bausch + Lomb launches ortho-k lens fitting system
Products

Bausch + Lomb launches ortho-k lens fitting system

The Arise cloud-based platform syncs directly with diagnostic tools to create a customized lens design for myopia treatment in mere seconds—without the need for a fitting set.
Rare tooth-in-eye surgery restores vision in the blind
Research

Rare tooth-in-eye surgery restores vision in the blind

First patients in Canada undergo osteo-odonto keratoprosthesis to regain eyesight after severe corneal blindness.
Atsena receives FDA Fast Track designation for XLRS gene therapy
Pipeline

Atsena receives FDA Fast Track designation for XLRS gene therapy

Subretinally-injected therapeutic is powered by dual AAV vectors with potential to become first approved treatment for this rare IRD.
Study identifies eye surgeon shortage in rural US
Research

Study identifies eye surgeon shortage in rural US

Growing disparity in number of rural subspecialist surgeons highlights need for improved patient access to eyecare.
How could new tariffs impact the optical industry?
Legal

How could new tariffs impact the optical industry?

The Vision Council dives into current and future impacts on eyewear amidst ongoing U.S. trade war against Canada, China, Mexico, and other countries.
How effective are autologous serum tears for Sjögren's syndrome at 50% concentration?
Research

How effective are autologous serum tears for Sjögren's syndrome at 50% concentration?

Serum tears showed improvements in DED signs and corneal nerve regeneration.
Glaukos and RadiusXR partner with Topcon on VF testing platform
Products

Glaukos and RadiusXR partner with Topcon on VF testing platform

Collaboration involves the launch of RadiusXR’s new wearable vision testing platform, the first tech of its kind to combine visual fields correlated to the clinical standard.
OKYO Pharma seeks Fast Track designation for NCP candidate
Pipeline

OKYO Pharma seeks Fast Track designation for NCP candidate

Designation would give urcosimod (formerly OK-101) an expedited pathway to potentially become the first approved treatment for this orphan disease. 
Nationwide survey links regular drinking with POAG
Research

Nationwide survey links regular drinking with POAG

Four or more drinks per week associated with an increased risk of primary open-angle glaucoma.
FDA accepts NDA for Sydnexis's low-dose atropine for pediatric myopia
Pipeline

FDA accepts NDA for Sydnexis's low-dose atropine for pediatric myopia

Once-daily drop features unique establishing excipient to avoid rapid atropine degradation; may become first eye drop with 3-year shelf-life.